Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Hyperlipidemia and Mixed Dyslipidemia”

Showing 8 of 0 results

Large-scale testing (Phase 3)Study completedNCT04781114
What this trial is testing

The Safety and Efficacy of Multiple-dose of JS002 in Subject With Hyperlipidemia

Who this might be right for
Hyperlipemia
Shanghai Junshi Bioscience Co., Ltd. 806
Large-scale testing (Phase 3)Study completedNCT05255458
What this trial is testing

Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia

Who this might be right for
Hyperlipidemia
Akeso 122
Large-scale testing (Phase 3)Study completedNCT01420549
What this trial is testing

Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslipidemia

Who this might be right for
HypercholesterolemiaDyslipidemia
Ache Laboratorios Farmaceuticos S.A. 129
Testing effectiveness (Phase 2)Ended earlyNCT00325455
What this trial is testing

MK0859 Dose-Ranging Study (0859-003)

Who this might be right for
HypercholesterolemiaMixed Hyperlipemia
Merck Sharp & Dohme LLC 500
Large-scale testing (Phase 3)Study completedNCT02100514
What this trial is testing

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events

Who this might be right for
Hyperlipidemia
Pfizer 746
Large-scale testing (Phase 3)Study completedNCT02458287
What this trial is testing

Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia

Who this might be right for
Hyperlipidemia
Pfizer 299
Testing effectiveness (Phase 2)Study completedNCT00941603
What this trial is testing

Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)

Who this might be right for
Primary HypercholesterolemiaMixed Hyperlipidemia
Merck Sharp & Dohme LLC 619
Early research (Phase 1)Study completedNCT00565292
What this trial is testing

MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED)

Who this might be right for
HypercholesterolemiaHyperlipidemia
Merck Sharp & Dohme LLC 50

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation